Literature DB >> 16780420

Direct binding of Cbl to Tyr568 and Tyr936 of the stem cell factor receptor/c-Kit is required for ligand-induced ubiquitination, internalization and degradation.

Kristina Masson1, Elke Heiss, Hamid Band, Lars Rönnstrand.   

Abstract

The ubiquitin E3 ligase Cbl has been shown to negatively regulate tyrosine kinase receptors, including the stem cell factor receptor/c-Kit. Impaired recruitment of Cbl to c-Kit results in a deregulated positive signalling that eventually can contribute to carcinogenesis. Here, we present results showing that Cbl is activated by the SFKs (Src family kinases) and recruited to c-Kit in order to trigger receptor ubiquitination. We demonstrate that phosphorylated Tyr568 and Tyr936 in c-Kit are involved in direct binding and activation of Cbl and that binding of the TKB domain (tyrosine kinase binding domain) of Cbl to c-Kit is specified by the presence of an isoleucine or leucine residue in position +3 to the phosphorylated tyrosine residue on c-Kit. Apart from the direct association between Cbl and c-Kit, we show that phosphorylation of Cbl by SFK members is required for activation of Cbl to occur. Moreover, we demonstrate that Cbl mediates monoubiquitination of c-Kit and that the receptor is subsequently targeted for lysosomal degradation. Taken together, our findings reveal novel insights into the mechanisms by which Cbl negatively regulates c-Kit-mediated signalling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16780420      PMCID: PMC1570160          DOI: 10.1042/BJ20060464

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  44 in total

1.  Proteasome inhibitors block a late step in lysosomal transport of selected membrane but not soluble proteins.

Authors:  P van Kerkhof; C M Alves dos Santos; M Sachse; J Klumperman; G Bu; G J Strous
Journal:  Mol Biol Cell       Date:  2001-08       Impact factor: 4.138

2.  Endocytosis of receptor tyrosine kinases is driven by monoubiquitylation, not polyubiquitylation.

Authors:  Yaron Mosesson; Keren Shtiegman; Menachem Katz; Yaara Zwang; Gyorgi Vereb; Janos Szollosi; Yosef Yarden
Journal:  J Biol Chem       Date:  2003-04-28       Impact factor: 5.157

3.  Src family kinases are involved in the differential signaling from two splice forms of c-Kit.

Authors:  Olexandr Voytyuk; Johan Lennartsson; Akira Mogi; Georgina Caruana; Sara Courtneidge; Leonie K Ashman; Lars Rönnstrand
Journal:  J Biol Chem       Date:  2003-01-02       Impact factor: 5.157

4.  Vascular endothelial growth factor-dependent down-regulation of Flk-1/KDR involves Cbl-mediated ubiquitination. Consequences on nitric oxide production from endothelial cells.

Authors:  Martine Duval; Sara Bédard-Goulet; Chantal Delisle; Jean-Philippe Gratton
Journal:  J Biol Chem       Date:  2003-03-19       Impact factor: 5.157

5.  A mutant EGF-receptor defective in ubiquitylation and endocytosis unveils a role for Grb2 in negative signaling.

Authors:  Hadassa Waterman; Menachem Katz; Chanan Rubin; Keren Shtiegman; Sara Lavi; Ari Elson; Thomas Jovin; Yosef Yarden
Journal:  EMBO J       Date:  2002-02-01       Impact factor: 11.598

6.  C-Cbl binds the CSF-1 receptor at tyrosine 973, a novel phosphorylation site in the receptor's carboxy-terminus.

Authors:  Kevin Wilhelmsen; Steve Burkhalter; Peter van der Geer
Journal:  Oncogene       Date:  2002-02-07       Impact factor: 9.867

7.  c-Cbl is involved in Met signaling in B cells and mediates hepatocyte growth factor-induced receptor ubiquitination.

Authors:  Taher E I Taher; Esther P M Tjin; Esther A Beuling; Jannie Borst; Marcel Spaargaren; Steven T Pals
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

8.  The c-Cbl/CD2AP complex regulates VEGF-induced endocytosis and degradation of Flt-1 (VEGFR-1).

Authors:  Satsuki Kobayashi; Asako Sawano; Yoshihisa Nojima; Masabumi Shibuya; Yoshiro Maru
Journal:  FASEB J       Date:  2004-03-04       Impact factor: 5.191

9.  The adapter protein APS associates with the multifunctional docking sites Tyr-568 and Tyr-936 in c-Kit.

Authors:  Patrik Wollberg; Johan Lennartsson; Eva Gottfridsson; Akihiko Yoshimura; Lars Rönnstrand
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

10.  Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation.

Authors:  Kaisa Haglund; Sara Sigismund; Simona Polo; Iwona Szymkiewicz; Pier Paolo Di Fiore; Ivan Dikic
Journal:  Nat Cell Biol       Date:  2003-05       Impact factor: 28.824

View more
  36 in total

1.  Human proteome-scale structural modeling of E2-E3 interactions exploiting interface motifs.

Authors:  Gozde Kar; Ozlem Keskin; Ruth Nussinov; Attila Gursoy
Journal:  J Proteome Res       Date:  2012-01-10       Impact factor: 4.466

2.  Structural Determinants of the Gain-of-Function Phenotype of Human Leukemia-associated Mutant CBL Oncogene.

Authors:  Scott A Nadeau; Wei An; Bhopal C Mohapatra; Insha Mushtaq; Timothy A Bielecki; Haitao Luan; Neha Zutshi; Gulzar Ahmad; Matthew D Storck; Masashi Sanada; Seishi Ogawa; Vimla Band; Hamid Band
Journal:  J Biol Chem       Date:  2017-01-12       Impact factor: 5.157

Review 3.  Degradation of activated protein kinases by ubiquitination.

Authors:  Zhimin Lu; Tony Hunter
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

4.  The D816V mutation of c-Kit circumvents a requirement for Src family kinases in c-Kit signal transduction.

Authors:  Jianmin Sun; Malin Pedersen; Lars Rönnstrand
Journal:  J Biol Chem       Date:  2009-03-05       Impact factor: 5.157

5.  A CSF-1 receptor phosphotyrosine 559 signaling pathway regulates receptor ubiquitination and tyrosine phosphorylation.

Authors:  Ying Xiong; Da Song; Yunfei Cai; Wenfeng Yu; Yee-Guide Yeung; E Richard Stanley
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

Review 6.  Roles of E3 ubiquitin ligases in cell adhesion and migration.

Authors:  Cai Huang
Journal:  Cell Adh Migr       Date:  2010-01-18       Impact factor: 3.405

7.  Proapoptotic activity of bortezomib in gastrointestinal stromal tumor cells.

Authors:  Sebastian Bauer; Joshua A Parry; Thomas Mühlenberg; Matthew F Brown; Danushka Seneviratne; Payel Chatterjee; Anna Chin; Brian P Rubin; Shih-Fan Kuan; Jonathan A Fletcher; Stefan Duensing; Anette Duensing
Journal:  Cancer Res       Date:  2009-12-22       Impact factor: 12.701

8.  Smap1 deficiency perturbs receptor trafficking and predisposes mice to myelodysplasia.

Authors:  Shunsuke Kon; Naoko Minegishi; Kenji Tanabe; Toshio Watanabe; Tomo Funaki; Won Fen Wong; Daisuke Sakamoto; Yudai Higuchi; Hiroshi Kiyonari; Katsutoshi Asano; Yoichiro Iwakura; Manabu Fukumoto; Motomi Osato; Masashi Sanada; Seishi Ogawa; Takuro Nakamura; Masanobu Satake
Journal:  J Clin Invest       Date:  2013-02-22       Impact factor: 14.808

9.  p85β regulatory subunit of class IA PI3 kinase negatively regulates mast cell growth, maturation, and leukemogenesis.

Authors:  Subha Krishnan; Raghuveer Singh Mali; Baskar Ramdas; Emily Sims; Peilin Ma; Joydeep Ghosh; Veerendra Munugalavadla; Philip Hanneman; Joal D Beane; Reuben Kapur
Journal:  Blood       Date:  2012-02-29       Impact factor: 22.113

Review 10.  A survival Kit for pancreatic beta cells: stem cell factor and c-Kit receptor tyrosine kinase.

Authors:  Zhi-Chao Feng; Matthew Riopel; Alex Popell; Rennian Wang
Journal:  Diabetologia       Date:  2015-02-03       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.